Call us directly: NY: 1-631-893-3903 or NJ: 1-201-342-7662

Or visit one of our three locations: View Locations

Click here to see our five-star patient satisfaction reviews on Healthgrades

Brian Mehling, MD

Bian Mehling, M.D., M.Sis a board-certified orthopedic trauma surgeon, researcher, and philanthropist. He is spearheading groundbreaking research in stem cell therapy through his company, BHI Therapeutic Sciences, Inc. an organization focused on treatment and research using stem cells.

BHI Therapeutic Sciences (BHITS), a leader in stem cell therapy and research utilizing human umbilical cord blood was recently notified by the Food and Drug Administration (FDA) that its Investigational New Drug (IND) application to allow for the initiation of a clinical study of an FDA-approved cell therapy (HCP, cord blood) for treatment of acute ischemic stroke may proceed.

 

Dr. Mehling started his path in medicine through undergraduate study at Harvard University, obtaining his Bachelor of Arts and Master of Science degrees in Biochemistry from Ohio State University.

Completing his degree of medicine at Wright State University School of Medicine, Dr. Mehling received post graduate education through residencies and fellowships at St. Joseph’s Hospital in Paterson, NJ and the Graduate Hospital in Philadelphia, PA, while pursuing a Ph.D. in Chemistry.

Click here to view Dr. Mehling’s CV